Skip to main content
. 2022 Apr 17;9(4):2445–2454. doi: 10.1002/ehf2.13941

Figure 2.

Figure 2

Association of a history of cancer and AF with composite of systemic thrombosis and major bleeding in overall and subgroups. Considering all‐cause death as the competing risk, the Fine and Gray model was adjusted for age, sex, New York Heart Association functional class, brain natriuretic peptide, heart rate, haemoglobin, history of stroke, and ischaemic heart disease (IHD). AC, anticoagulant; AF, atrial fibrillation; HR, hazard ratio; LVEF, left ventricular ejection fraction.